AG Mednet Introduces Remote, Non-DICOM File Systems for Clinical Trials, Improves Data Quality - Applied Clinical Trials

ADVERTISEMENT

See our 2013 Buyers Guide Digital Edition.
AG Mednet Introduces Remote, Non-DICOM File Systems for Clinical Trials, Improves Data Quality

Source: Company News Release

AG Mednet has announced the availability of new capabilities to enable sponsors, CROs and core laboratories to take delivery of electronic trial data into configurable file structures residing either locally or in any of their network shares. This functionality provides higher-quality data and less delays, making it the most efficient method to collect and transfer Holter data, spectral-domain OCT and newer modalities not yet conforming to the DICOM standard.

Now, meta-data can be assigned to non-DICOM modalities and used for configuring, on a per-study basis, structured directories with explicit hierarchies based on the acquired meta-data. This is especially important for:

  • Sites participating in AG Mednet-based clinical trials. The assembly and delivery of imaging submissions remains consistent across both DICOM and non-DICOM data sets;
  • Sponsors, CROs and core laboratories. Non-DICOM modalities are delivered to a file system-based infrastructure, while DICOM modalities are delivered either to a standard DICOM environment, or the same file system-based infrastructure.
“In combination with our ability to tag and deliver this data not just to DICOM repositories but also to local file systems, we’re providing cardiovascular trials, as well as projects requiring specialized non-DICOM modalities, with a way to ensure higher quality and less delays than other methods,” said Abraham Gutman, President & CEO of AG Mednet.

For more information about AG Mednet, please visit www.agmednet.com.

ADVERTISEMENT

blog comments powered by Disqus

ADVERTISEMENT

Survey
As it creates a plan to implement the US biosimilar pathway, should FDA:
Borrow heavily from EMA's pathway program?
Borrow lightly from EMA's pathway program?
Create entirely its own pathway program?
Borrow heavily from EMA's pathway program?
86%
Borrow lightly from EMA's pathway program?
6%
Create entirely its own pathway program?
7%
View Results
Untitled Document
Source: Company News Release,
Click here